Cita APA

Selma, M. V., González-Sarrías, A., Salas Salvadó, J., Andrés Lacueva, M. C., Alasalvar, C., Örem, A., . . . Espín, J. C. (2017). The gut microbiota metabolism of pomegranate or walnut ellagitannins yields two urolithin-metabotypes that correlate with cardiometabolic risk biomarkers: Comparison between normoweight, overweight-obesity and metabolic syndrome.

Citación estilo Chicago

Selma, María Victoria, Antonio González-Sarrías, Jordi Salas Salvadó, Ma. Cristina Andrés Lacueva, Cesarettin Alasalvar, Asim Örem, F. A. (Francisco A.) Tomas-Barberan, y Juan Carlos Espín. The Gut Microbiota Metabolism of Pomegranate or Walnut Ellagitannins Yields Two Urolithin-metabotypes That Correlate With Cardiometabolic Risk Biomarkers: Comparison between Normoweight, Overweight-obesity and Metabolic Syndrome. 2017.

Cita MLA

Selma, María Victoria, et al. The Gut Microbiota Metabolism of Pomegranate or Walnut Ellagitannins Yields Two Urolithin-metabotypes That Correlate With Cardiometabolic Risk Biomarkers: Comparison between Normoweight, Overweight-obesity and Metabolic Syndrome. 2017.